CoChat

Plaque and tangle imaging and cognition in normal aging and Alzheimer's disease

Open access
Braskie, Meredith N., Klunder, Andrea D., Hayashi, Kiralee M., Protas, Hillary, Kepe, Vladimir, Miller, Karen J., Huang, S.-C., Barrio, Jorge R., Ercoli, Linda M., Siddarth, Prabha, Satyamurthy, Nagichettiar, Liu, Jie, Toga, Arthur W., Bookheimer, Susan Y., Small, Gary W., Thompson, Paul M. · 2010 · Neurobiology of Aging
Cited by 114

The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.

Abstract

Amyloid plaques and tau neurofibrillary tangles, the pathological hallmarks of Alzheimer’s disease (AD), begin accumulating in the healthy human brain decades before clinical dementia symptoms can be detected. There is great interest in how this pathology spreads in the living brain and its association with cognitive deterioration. Using MRI-derived cortical surface models and four-dimensional animation techniques, we related cognitive ability to positron emission tomography (PET) signal from 2-(1-{6-[(2-[F-18]fluoroethyl)(methyl)amino]-2-naphthyl}ethylidene)malononitrile ([18F]FDDNP), a molecular imaging probe for plaques and tangles. We examined this relationship at each cortical surface point in 23 older adults (10 cognitively intact, 6 with amnestic mild cognitive impairment, 7 with AD). [18F]FDDNP-PET signal was highly correlated with cognitive performance, even in cognitively intact subjects. Animations of [18F]FDDNP signal growth with decreased cognition across all subjects (http://www.loni.ucla.edu/~thompson/FDDNP/video.html) mirrored the classic Braak and Braak trajectory in lateral temporal, parietal, and frontal cortices. Regions in which cognitive performance was significantly correlated with [18F]FDDNP signal include those that deteriorate earliest in AD, suggesting the potential utility of [18F]FDDNP for early diagnosis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.neurobiolaging.2008.09.012

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 14 references

Research works printed but not linked: 23

  1. Agdeppa, 2001, Binding characteristics of radiofluorinated 6-dialkylamino-2-naphthylethylidene derivatives as positron emission tomography imaging probes for beta-amyloid plaques in Alzheimer's disease, J. Neurosci., 21, RC189, 10.1523/JNEUROSCI.21-24-j0004.2001 · DOI · Paper page
  2. Agdeppa, 2001, In vivo and in vitro labeling of plaques and tangles in the brain of an Alzheimer's disease patient: a case study, Ann. Meet. J. Nuclear Med., 42, 65P
  3. Apostolova, 2006, 3D mapping of mini-mental state examination performance in clinical and preclinical Alzheimer disease, Alzheimer Dis. Assoc. Disord., 20, 224, 10.1097/01.wad.0000213857.89613.10 · DOI · Paper page
  4. Binder, 2005, Tau, tangles, and Alzheimer's disease, Biochim. Biophys. Acta, 1739, 216, 10.1016/j.bbadis.2004.08.014 · DOI · Paper page
  5. Castellani, 2006, Antioxidant protection and neurodegenerative disease: the role of amyloid-beta and tau, Am. J. Alzheimers Dis. Other Demen., 21, 126, 10.1177/153331750602100213 · DOI · Paper page
  6. Hamilton, 1960, A rating scale for depression, J. Neurol. Neurosurg. Psychiat., 23, 56, 10.1136/jnnp.23.1.56 · DOI · Paper page
  7. Jones, 2006, Differential verbal fluency deficits in the preclinical stages of Alzheimer's disease and vascular dementia, Cortex, 42, 347, 10.1016/S0010-9452(08)70361-7 · DOI
  8. Klunk, 2004, Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B, Ann. Neurol., 55, 306, 10.1002/ana.20009 · DOI · Paper page
  9. Lerch, 2005, Focal decline of cortical thickness in Alzheimer's disease identified by computational neuroanatomy, Cereb. Cortex, 15, 995, 10.1093/cercor/bhh200 · DOI · Paper page
  10. Liu, 2007, High-yield, automated radiosynthesis of 2-(1-{6-[(2-[18F]fluoroethyl)(methyl)amino]-2-naphthyl}ethylidene)malononitrile ([18F]FDDNP) ready for animal or human administration, Mol. Imag. Biol., 9, 6, 10.1007/s11307-006-0061-4 · DOI
  11. Logan, 1996, Distribution volume ratios without blood sampling from graphical analysis of PET data, J. Cereb. Blood Flow Metab., 16, 834, 10.1097/00004647-199609000-00008 · DOI · Paper page
  12. MacDonald, 2000, Automated 3D extraction of inner and outer surfaces of cerebral cortex from MRI, Neuroimage, 12, 340, 10.1006/nimg.1999.0534 · DOI · Paper page
  13. McKhann, 1984, Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease, Neurology, 34, 939, 10.1212/WNL.34.7.939 · DOI · Paper page
  14. Petersen, 2004, Mild cognitive impairment as a diagnostic entity, J. Intern. Med., 256, 183, 10.1111/j.1365-2796.2004.01388.x · DOI · Paper page
  15. Selkoe, 2001, Alzheimer's disease results from the cerebral accumulation and cytotoxicity of amyloid beta-protein, J. Alzheimer's Dis., 3, 75, 10.3233/JAD-2001-3111 · DOI · Paper page
  16. Shattuck, 2001, Magnetic resonance image tissue classification using a partial volume model, Neuroimage, 13, 856, 10.1006/nimg.2000.0730 · DOI · Paper page
  17. Small, 2006, PET of brain amyloid and tau in mild cognitive impairment, N. Engl. J. Med., 355, 2652, 10.1056/NEJMoa054625 · DOI · Paper page
  18. Smith, 2002, Fast robust automated brain extraction, Hum. Brain Mapp., 17, 143, 10.1002/hbm.10062 · DOI · Paper page
  19. Sowell, 2004, Longitudinal mapping of cortical thickness and brain growth in normal children, J. Neurosci., 24, 8223, 10.1523/JNEUROSCI.1798-04.2004 · DOI · Paper page
  20. Tabert, 2006, Neuropsychological prediction of conversion to Alzheimer disease in patients with mild cognitive impairment, Arch. Gen. Psychiat., 63, 916, 10.1001/archpsyc.63.8.916 · DOI · Paper page
  21. Thompson, 2004, Mapping cortical change in Alzheimer's disease, brain development, and schizophrenia, Neuroimage, 23, S2, 10.1016/j.neuroimage.2004.07.071 · DOI · Paper page
  22. Verhoeff, 2004, In-vivo imaging of Alzheimer disease beta-amyloid with [11C]SB-13 PET, Am. J. Geriatr. Psychiat., 12, 584
  23. Watson, 2005, Physicochemical characteristics of soluble oligomeric A beta and their pathologic role in Alzheimer's disease, Neurol. Res., 27, 869, 10.1179/016164105X49436 · DOI · Paper page

Cited by

See all 114

Metadata

Authors
Braskie, M. N., Klunder, A. D., Hayashi, K. M., Protas, H., Kepe, V., Miller, K. J., Huang, S.-C., Barrio, J. R., Ercoli, L. M., Siddarth, P., Satyamurthy, N., Liu, J., Toga, A. W., Bookheimer, S. Y., Small, G. W., & Thompson, P. M.
Venue
Neurobiology of Aging
Publisher
Elsevier BV
Published
2010-10
Volume
31
Issue
10
Pages
1669-1678
ISSN
0197-4580 (ISSN-L)
OpenAlex
W2075342209
Cited by
114
References
14
FWCI
10.03
Type
journal article
Language
en
Open access
green
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)
Funders
  • U.S. Department of Energy (DE-FC03-87-ER60615)
  • National Institute of Biomedical Imaging and Bioengineering
  • National Institute of Neurological Disorders and Stroke
  • Alzheimer's Association
  • National Institute on Aging
  • Larry L. Hillblom Foundation
  • National Institutes of Health (AG13308, AG10123, P01-AG024831, P50 AG 16570, MH52453, MH/AG58156, M01-RR00865)
  • National Center for Research Resources
  • Ahmanson Foundation
  • U.S. National Library of Medicine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Plaque and tangle imaging and cognition in normal aging and Alzheimer's disease. https://app.cochat.ai/papers/10.1016/j.neurobiolaging.2008.09.012
The paper
Braskie, M. N., Klunder, A. D., Hayashi, K. M., Protas, H., Kepe, V., Miller, K. J., Huang, S.-C., Barrio, J. R., Ercoli, L. M., Siddarth, P., Satyamurthy, N., Liu, J., Toga, A. W., Bookheimer, S. Y., Small, G. W., & Thompson, P. M. (2010). Plaque and tangle imaging and cognition in normal aging and Alzheimer's disease. Neurobiology of Aging. https://doi.org/10.1016/j.neurobiolaging.2008.09.012

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.